Pradeep Sinha, MD To Hold Trials For Latest Advance In Facial Fillers
Main Category: Cosmetic Medicine / Plastic SurgeryArticle Date: 21 Oct 2006 - 0:00 PDT
| Patient / Public: | ![]() |
5 (2 votes) |
| Healthcare Prof: | ![]() |
2.5 (2 votes) |
Dr. Pradeep Sinha, board certified facial plastic surgery specialist of The Atlanta Institute for Facial Aesthetic Surgery, has been selected by Allergan, the maker of BOTOX(R) Cosmetic, as one of the physicians nationwide to hold clinical trials of the latest advance in FDA-approved facial fillers, JUVEDERM(TM) ULTRA and JUVEDERM(TM) ULTRA PLUS.
JUVEDERM(TM) ULTRA and JUVEDERM(TM) ULTRA PLUS are technologically advanced hyaluronic acid dermal fillers that provide volume for deeper facial folds and lasts for up to six months, or longer.
Dr. Sinha will hold an open-label trial in the Atlanta area later this month to gain information on the new products. As a testing physician, Dr. Sinha will begin offering JUVEDERM(TM) ULTRA products to the general public the first of December, while both JUVEDERM(TM) ULTRA products will be available through physicians' offices in January 2007.
"My patients have been awaiting the arrival of a facial filler that lasts longer and provides a smoother, better result," says Dr. Sinha, "and we believe the JUVEDERM(TM) ULTRA and JUVEDERM(TM) ULTRA PLUS trials will demonstrate that that product is here."
On June 2, 2006 the FDA approved the Juvederm(R) family of products, a 'next generation' of smooth gel, non-animal hyaluronic acid dermal fillers offering a natural look and feel and long-lasting results for up to six months or longer. Juvederm(R)'s long duration of effect may be attributed to the fact that it is the only dermal filler currently available on the market with the highest concentration of cross-linked hyaluronic acid and a special proprietary formulation process. It also is currently the only approved hyaluronic acid dermal filler that has demonstrated its safety and effectiveness in patients of all skin types and colors.
The Atlanta Institute for Facial Aesthetic Surgery offers a comprehensive array of the most advanced surgical, laser and office-based procedures for restoring, refining and rejuvenating the face, customized for each individual patient in a warm, professional setting. Selected as one of the few BOTOX(R) National Training Centers and Georgia's only Lumenis Center of Excellence for aesthetic lasers, the practice is on the forefront of the latest cosmetic procedures. For more information on JUVEDERM(TM) ULTRA and JUVEDERM(TM) ULTRA PLUS, The Atlanta Institute for Facial Aesthetic Surgery or Dr. Sinha's clinical trials, go to http://www.facialaestheticsurgery.com/ or contact Lisa DeGirolamo at 404-256-5428.
The Atlanta Institute for Facial Aesthetic Surgery
http://www.facialaestheticsurgery.com/
Visit our cosmetic medicine / plastic surgery section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/54702.php>
APA
http://www.medicalnewstoday.com/releases/54702.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





